Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Duchenne muscular dystrophy (DMD), a fatal musculoskeletal disease, is associated with neurodevelopmental disorders and cognitive impairment caused by brain dystrophin deficiency. Dog models of DMD represent key translational tools to study dystrophin biology and to develop novel therapeutics. However, characterisation of dystrophin expression and function in the canine brain is lacking. We studied the DE50-MD canine model of DMD that has a missense mutation in the donor splice site of exon 50. Using a battery of cognitive tests, we detected a neurocognitive phenotype in DE50-MD dogs, including reduced attention, problem solving and exploration of novel objects. Through a combination of capillary immunoelectrophoresis, immunolabelling, quantitative PCR and RNAScope in situ hybridisation, we show that regional dystrophin expression in the adult canine brain reflects that of humans, and that the DE50-MD dog lacks full-length dystrophin (Dp427) protein expression but retains expression of the two shorter brain-expressed isoforms, Dp140 and Dp71. Thus, the DE50-MD dog is a translationally relevant pre-clinical model to study the consequences of Dp427 deficiency in the brain and to develop therapeutic strategies for the neurological sequelae of DMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies on the canine brain are limited to the DE50-MD dog (which has a missense mutation in the donor splice site of exon 50 and consequently lacks only Dp427), which have reported reduced attention, problem solving and exploration of novel objects (Crawford et al., 2022), as well as regional reductions in grey matter and increased ventricular volume (Crawford et al., 2023).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Crawford et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
X chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765 · cited 1×
“Much of the available information on dystrophin expression and function is derived from animal models, including mouse (Bulfield et al., 1984), rat (Larcher et al., 2014), dog (Walmsley et al., 2010; Kornegay, 2017) and pig (Klymiuk et al., 2013).”
Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
Amoasii, L., Hildyard, J. C. W., Li, H., Sanchez-Ortiz, E., Mireault, A., Caballero, D., Harron, R., Stathopoulou, T.-R., Massey, C., Shelton, J. M., et al. (2018) · Science · doi:10.1126/science.aau1549 · Cited by 546 · cited 3×
“…has been on correcting the muscle phenotype, encouraging progress in this area (Bengtsson et al., 2017; Goyenvalle et al., 2015; Wang et al., 2012; Amoasii et al., 2018) means that the longer-term impact of early-life cognitive deficits will likely become clearer and more pertinent in the near…”
Self-citationBengtsson, N. E., Hall, J. K., Odom, G. L., Phelps, M. P., Andrus, C. R., Hawkins, R. D., Hauschka, S. D., Chamberlain, J. R., & Chamberlain, J. S. (2017) · Nature Communications · doi:10.1038/ncomms14454 · Cited by 387
Attentional Capacities in Children with Autism: Is There a General Deficit in Shifting Focus?
Pascualvaca, D. M., Fantie, B. D., Papageorgiou, M., & Mirsky, A. F. (1998) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1026091809650 · Cited by 191 · cited 1×
“Additionally, perseveration in extinction has been linked with autism (Hughes et al., 1994; Landry and Mitchell, 2021; Pascualvaca et al., 1998) and a reduced blink rate with ADHD (Konrad et al., 2003), thus facilitating assessment of potentially associated neurobehavioural disorders.”
Vaillend, C., Billard, J.-M., & Laroche, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.05.004 · Cited by 169
Vaillend, C., Rendon, A., Misslin, R., & Ungerer, A. (1995) · Behavior Genetics · doi:10.1007/bf02327580 · Cited by 112 · cited 2×
“Reported findings include deficits in passive avoidance behaviour (Muntoni et al., 1991), enhanced defensive freezing (Sekiguchi et al., 2009), long delays in spontaneous alternation tasks (Vaillend et al., 1995), and impaired long-term spatial and recognition memory (Vaillend et al., 2004).”
Research works printed but not linked: 83
- Agostino, 2008, Voluntary, spontaneous, and reflex blinking in Parkinson's disease, Mov. Disord., 23, 669, 10.1002/mds.21887 · DOI
- Austin, 1995, Cloning and characterization of alternatively spliced isoforms of Dp71, Hum. Mol. Genet., 4, 1475, 10.1093/hmg/4.9.1475 · doi:10.1093/hmg/4.9.1475
- Banihani, 2015, Cognitive and neurobehavioral profile in boys with Duchenne muscular dystrophy, J. Child Neurol., 30, 1472, 10.1177/0883073815570154 · DOI · Paper page
- Bar, 1990, A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution, Biochem. J., 272, 557, 10.1042/bj2720557 · DOI · Paper page
- Bardoni, 2000, Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies, Neuromuscul. Disord., 10, 194, 10.1016/S0960-8966(99)00108-X · DOI
- Bologna, 2009, Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy, Brain, 132, 502, 10.1093/brain/awn317 · DOI
- Byers, 1993, An alternative dystrophin transcript specific to peripheral nerve, Nat. Genet., 4, 77, 10.1038/ng0593-77 · DOI · Paper page
- Caplan, 1998, Blink rate in pediatric complex partial seizure disorder, J. Child Psychol. Psychiatry, 39, 1145, 10.1111/1469-7610.00418 · DOI
- Carter, 1996, A splicing-dependent regulatory mechanism that detects translation signals, EMBO J., 15, 5965, 10.1002/j.1460-2075.1996.tb00983.x · DOI · Paper page
- Chamova, 2013, Association between loss of dp140 and cognitive impairment in duchenne and becker dystrophies, Balkan. J. Med. Genet., 16, 21, 10.2478/bjmg-2013-0014 · DOI · Paper page
- Cotton, 2001, Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients, Dev. Med. Child Neurol., 43, 497, 10.1017/S0012162201000913 · DOI · Paper page
- Crawford, 2021, Identification of quantitative polymerase chain reaction reference genes suitable for normalising gene expression in the brain of normal and dystrophic mice and dogs, Wellcome Open Res., 6, 84, 10.12688/wellcomeopenres.16707.1 · doi:10.12688/wellcomeopenres.16707.1
- Daffner, 1994, The impact of aging on curiosity as measured by exploratory eye movements, Arch. Neurol., 51, 368, 10.1001/archneur.1994.00540160062009 · DOI
- Daffner, 1999, Mechanisms underlying diminished novelty-seeking behavior in patients with probable Alzheimer's disease, Neuropsychiatr. Neuropsychol. Behav. Neurol., 12, 58
- Daffner, 2000, The central role of the prefrontal cortex in directing attention to novel events, Brain, 123, 927, 10.1093/brain/123.5.927 · DOI · Paper page
- Daffner, 2006, Increased responsiveness to novelty is associated with successful cognitive aging, J. Cogn. Neurosci., 18, 1759, 10.1162/jocn.2006.18.10.1759 · DOI
- Daoud, 2008, Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions, PLoS ONE, 4, e6574, 10.1371/journal.pone.0006574 · DOI · Paper page
- Doorenweerd, 2014, Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy, Ann. Neurol., 76, 403, 10.1002/ana.24222 · DOI · Paper page
- Doorenweerd, 2017, Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy, Sci. Rep., 7, 12575, 10.1038/s41598-017-12981-5 · DOI · Paper page
- D'souza, 1995, A novel dystrophin isoform is required for normal retinal electrophysiology, Hum. Mol. Genet., 4, 837, 10.1093/hmg/4.5.837 · DOI · Paper page
- Fabiani, 1998, Individual differences in P3 scalp distribution in older adults, and their relationship to frontal lobe function, Psychophysiology, 35, 698, 10.1111/1469-8986.3560698 · doi:10.1111/1469-8986.3560698 · Paper page
- Fitzpatrick, 2012, Case-control study of blink rate in Parkinson's disease under different conditions, J. Neurol., 259, 739, 10.1007/s00415-011-6261-0 · DOI
- Gallup, 1968, Mirror-image stimulation, Psychol. Bull., 70, 782, 10.1037/h0026777 · DOI · Paper page
- González-Martínez, 2013, Effect of age and severity of cognitive dysfunction on two simple tasks in pet dogs, Vet. J., 198, 176, 10.1016/j.tvjl.2013.07.004 · DOI
- Górecki, 1992, Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters, Hum. Mol. Genet., 1, 505, 10.1093/hmg/1.7.505 · DOI · Paper page
- Goyenvalle, 2015, Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers, Nat. Med., 21, 270, 10.1038/nm.3765 · DOI · Paper page
- Hendriksen, 2008, Neuropsychiatric disorders in males with duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive--compulsive disorder, J. Child Neurol., 23, 477, 10.1177/0883073807309775 · DOI · Paper page
- Hildyard, 2018, Determination of qPCR reference genes suitable for normalizing gene expression in a canine model of Duchenne muscular dystrophy, J. Neuromuscul. Dis., 5, 177, 10.3233/JND-170267 · DOI
- Hildyard, 2019, Identification of qPCR reference genes suitable for normalizing gene expression in the mdx mouse model of Duchenne muscular dystrophy, PLoS ONE, 14, e0211384, 10.1371/journal.pone.0211384 · DOI
- Hildyard, 2020, Single-transcript multiplex in situ hybridisation reveals unique patterns of dystrophin isoform expression in the developing mammalian embryo, Wellcome Open Res., 5, 76, 10.12688/wellcomeopenres.15762.1 · DOI
- Hildyard, 2020, Multiplex in situ hybridization within a single transcript: RNAscope reveals dystrophin mRNA dynamics, PLoS ONE, 15, e0239467, 10.1371/journal.pone.0239467 · DOI
- Hornby, 2021, Musculoskeletal magnetic resonance imaging in the DE50-MD dog model of Duchenne muscular dystrophy, Neuromuscul. Disord., 31, 736, 10.1016/j.nmd.2021.05.010 · DOI
- Hughes, 1994, Evidence for executive dysfunction in autism, Neuropsychologia, 32, 477, 10.1016/0028-3932(94)90092-2 · DOI · Paper page
- Klymiuk, 2013, Dystrophin-deficient pigs provide new insights into the hierarchy of physiological derangements of dystrophic muscle, Hum. Mol. Genet., 22, 4368, 10.1093/hmg/ddt287 · DOI · Paper page
- Knuesel, 1999, Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice), Eur. J. Neurosci., 11, 4457, 10.1046/j.1460-9568.1999.00887.x · DOI · Paper page
- Kodippili, 2018, Dual AAV gene therapy for duchenne muscular dystrophy with a 7-kb mini-dystrophin gene in the Canine model, Hum. Gene. Ther., 29, 299, 10.1089/hum.2017.095 · DOI · Paper page
- Koenig, 1989, The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion, Am. J. Hum. Genet., 45, 498
- Konrad, 2003, Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder, Brain Res. Cogn. Brain Res., 16, 425, 10.1016/S0926-6410(03)00057-0 · DOI
- Kornegay, 2017, The golden retriever model of Duchenne muscular dystrophy, Skelet. Muscle, 7, 9, 10.1186/s13395-017-0124-z · DOI · Paper page
- Landry, 2021, An examination of perseverative errors and cognitive flexibility in autism, PLoS ONE, 16, e0223160, 10.1371/journal.pone.0223160 · DOI
- Larcher, 2014, Characterization of dystrophin deficient rats: a new model for Duchenne muscular dystrophy, PLoS ONE, 9, e110371, 10.1371/journal.pone.0110371 · DOI · Paper page
- Lawrence, 1991, The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeys, Life Sci., 49, PL229, 10.1016/0024-3205(91)90299-Q · DOI
- Lazarowski, 2014, Acquisition of a visual discrimination and reversal learning task by Labrador retrievers, Anim. Cogn., 17, 787, 10.1007/s10071-013-0712-1 · DOI
- Lederfein, 1992, A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues, Proc. Natl. Acad. Sci. USA, 89, 5346, 10.1073/pnas.89.12.5346 · DOI · Paper page
- Lidov, 1990, Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons, Nature, 348, 725, 10.1038/348725a0 · DOI · Paper page
- Lidov, 1995, Dp140 - a Novel 140-Kda Cns Transcript from the Dystrophin Locus, Hum. Mol. Genet., 4, 329, 10.1093/hmg/4.3.329 · DOI · Paper page
- Luria, 1969, Handbook of Clinical Neurology.
- Mah, 2014, A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy, Neuromuscul. Disord., 24, 482, 10.1016/j.nmd.2014.03.008 · DOI · Paper page
- Mavridis, 1991, Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease, Neuroscience, 41, 507, 10.1016/0306-4522(91)90345-O · DOI · Paper page
- McGreevy, 2015, Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy, Dis. Model. Mech., 8, 195, 10.1242/dmm.018424 · DOI · Paper page
- Milner, 1964, The Frontal Granular Cortex and Behaviour.
- Miranda, 2011, Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71, Neurobiol. Dis., 43, 134, 10.1016/j.nbd.2011.02.017 · DOI
- Muntoni, 1991, Passive avoidance behaviour deficit in the mdx mouse, Neuromuscul. Disord., 1, 121, 10.1016/0960-8966(91)90059-2 · DOI · Paper page
- Muntoni, 1993, Muscular weakness in the mdx mouse, J. Neurol. Sci., 120, 71, 10.1016/0022-510X(93)90027-V · DOI
- Naidoo, 2020, Dystrophin Dp71 and the neuropathophysiology of Duchenne muscular dystrophy, Mol. Neurobiol., 57, 1748, 10.1007/s12035-019-01845-w · DOI
- Nicholson, 1993, Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 3. Differential diagnosis and prognosis, J. Med. Genet., 30, 745, 10.1136/jmg.30.9.745 · DOI
- Noer, 2015, Context matters: multiple novelty tests reveal different aspects of shyness-boldness in farmed american mink (Neovison vison), PLoS ONE, 10, e0130474, 10.1371/journal.pone.0130474 · DOI
- Nudel, 1989, Duchenne muscular dystrophy gene product is not identical in muscle and brain, Nature, 337, 76, 10.1038/337076a0 · DOI · Paper page
- Packer, 2018, Cognitive dysfunction in naturally occurring canine idiopathic epilepsy, PLoS ONE, 13, e0192182, 10.1371/journal.pone.0192182 · DOI
- Packer, 2018, Negative effects of epilsepsy and antiepileptic drugs on the trainability of dogs with naturally occurring idiopathic epilepsy, Appl. Anim. Behav. Sci., 200, 106, 10.1016/j.applanim.2017.11.008 · DOI
- Pane, 2013, Duchenne muscular dystrophy and epilepsy, Neuromuscul. Disord., 23, 313, 10.1016/j.nmd.2013.01.011 · DOI · Paper page
- Protopopova, 2014, Association between increased behavioral persistence and stereotypy in the pet dog, Behav. Processes, 106, 77, 10.1016/j.beproc.2014.04.009 · DOI
- Rall, 2012, Survival in Duchenne muscular dystrophy, 31, 117
- Remmelink, 2016, Cognitive flexibility deficits in a mouse model for the absence of full-length dystrophin, Genes Brain Behav., 15, 558, 10.1111/gbb.12301 · DOI · Paper page
- Sanchez, 2018, Clinical and genetic characterisation of dystrophin-deficient muscular dystrophy in a family of Miniature Poodle dogs, PLoS ONE, 13, e0193372, 10.1371/journal.pone.0193372 · DOI
- Sarig, 1999, Targeted inactivation of Dp71, the major non-muscle product of the DMD gene: differential activity of the Dp71 promoter during development, Hum. Mol. Genet., 8, 1, 10.1093/hmg/8.1.1 · DOI
- Schütt, 2016, Dogs with cognitive dysfunction as a spontaneous model for early Alzheimer's disease: a translational study of neuropathological and inflammatory markers, J. Alzheimers Dis., 52, 433, 10.3233/JAD-151085 · DOI · Paper page
- Sekiguchi, 2009, A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice, Brain, 132, 124, 10.1093/brain/awn253 · DOI · Paper page
- Sharp, 1992, An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy, Genomics, 13, 115, 10.1016/0888-7543(92)90210-J · DOI · Paper page
- Siwak, 2001, Effect of age and level of cognitive function on spontaneous and exploratory behaviors in the beagle dog, Learn. Mem., 8, 317, 10.1101/lm.41701 · DOI
- Song, 2019, Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models, Nat. Med., 25, 1505, 10.1038/s41591-019-0594-0 · DOI · Paper page
- Supek, 2020, To NMD or not to NMD: nonsense-mediated mRNA decay in cancer and other genetic diseases, Trends Genet., 37, 657, 10.1016/j.tig.2020.11.002 · DOI · Paper page
- Sussman, 2002, Duchenne muscular dystrophy, J. Am. Acad. Orthop. Surg., 10, 138, 10.5435/00124635-200203000-00009 · DOI
- Sweeney, 2000, The dystrophin-associated glycoprotein complex: what parts can you do without?, Proc. Natl. Acad. Sci. USA, 97, 13464, 10.1073/pnas.011510597 · DOI
- Tadayoni, 2012, Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene, Mol. Neurobiol., 45, 43, 10.1007/s12035-011-8218-9 · DOI
- Taylor, 2010, Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy, PLoS ONE, 5, e8803, 10.1371/journal.pone.0008803 · DOI · Paper page
- Tennyson, 1995, The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced, Nat. Genet., 9, 184, 10.1038/ng0295-184 · DOI · Paper page
- Vaillend, 2017, Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice, Hum. Mol. Genet., 26, 1041, 10.1093/hmg/ddx013 · DOI · Paper page
- Vaillend, 2010, Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse, Mol. Ther., 18, 1683, 10.1038/mt.2010.134 · DOI · Paper page
- Waite, 2012, The dystrophin-glycoprotein complex in brain development and disease, Trends Neurosci., 35, 487, 10.1016/j.tins.2012.04.004 · DOI · Paper page
- Walhovd, 2001, Two- and three-stimuli auditory oddball ERP tasks and neuropsychological measures in aging, Neuroreport, 12, 3149, 10.1097/00001756-200110080-00033 · doi:10.1097/00001756-200110080-00033
- Walmsley, 2010, A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping, PLoS ONE, 5, e8647, 10.1371/journal.pone.0008647 · DOI
- Wang, 2012, Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies, Mol. Ther., 20, 1501, 10.1038/mt.2012.111 · DOI · Paper page
Cited by
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Crawford, A. H., Hildyard, J. C. W., Rushing, S. A. M., Wells, D. J., Diez-Leon, M., & Piercy, R. J.
- Affiliations
- Comparative Neuromuscular Diseases Laboratory, Department of Clinical Science and Services, Royal Veterinary College, London NW1 0TU, UK
- Department of Comparative Biomedical Sciences, Royal Veterinary College, London NW1 0TU, UK
- Pathobiology and Population Sciences, Royal Veterinary College, London AL9 7TA, UK
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2022-03-01
- Volume
- 15
- Issue
- 3
- ISSN
- 1754-8403
- 1754-8411
- Cited by
- 17
- References
- 6
- Language
- en
- Funders
- Wellcome Trust (101550/Z/13/Z)
- Academy of Medical Sciences
- Medical Research Council
- British Heart Foundation
- Versus Arthritis
- Diabetes UK
- British Thoracic Society
- Association of Physicians of Great Britain and Ireland (SGL020\1081)
- Royal Veterinary College (1185 1718)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy. https://app.cochat.ai/papers/10.1242/dmm.049291
- The paper
- Crawford, A. H., Hildyard, J. C. W., Rushing, S. A. M., Wells, D. J., Diez-Leon, M., & Piercy, R. J. (2022). Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.049291
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.